| Title: |
Healthcare-Associated Respiratory Syncytial Virus in Children’s Hospitals |
| Authors: |
Saiman, Lisa; Coffin, Susan E; Kociolek, Larry K; Zerr, Danielle M; Milstone, Aaron M; Aldrich, Margaret L; Vargas, Celibell Y; Zapata, Giovanny; Zalot, Morgan A; Reyna, Megan E; Adler, Amanda; Voskertchian, Annie; Egbert, Emily R; Alba, Luis; Gollerkeri, Sonia; Ruggieri, Madelyn; Finelli, Lyn; Choi, Yoonyoung |
| Contributors: |
Merck Sharp & Dohme LLC; Merck & Co., Inc; Spring SHEA, Colorado Springs, CO |
| Source: |
Journal of the Pediatric Infectious Diseases Society ; volume 12, issue 5, page 265-272 ; ISSN 2048-7207 |
| Publisher Information: |
Oxford University Press (OUP) |
| Publication Year: |
2023 |
| Description: |
Background Outbreaks of healthcare-associated respiratory syncytial virus (HA-RSV) infections in children are well described, but less is known about sporadic HA-RSV infections. We assessed the epidemiology and clinical outcomes associated with sporadic HA-RSV infections. Methods We retrospectively identified hospitalized children ≤18 years old with HA-RSV infections in six children’s hospitals in the United States during the respiratory viral seasons October–April in 2016–2017, 2017–2018, and 2018–2019 and prospectively from October 2020 through November 2021. We evaluated outcomes temporally associated with HA-RSV infections including escalation of respiratory support, transfer to the pediatric intensive care unit (PICU), and in-hospital mortality. We assessed demographic characteristics and comorbid conditions associated with escalation of respiratory support. Results We identified 122 children (median age 16.0 months [IQR 6, 60 months]) with HA-RSV. The median onset of HA-RSV infections was hospital day 14 (IQR 7, 34 days). Overall, 78 (63.9%) children had two or more comorbid conditions; cardiovascular, gastrointestinal, neurologic/neuromuscular, respiratory, and premature/ neonatal comorbidities were most common. Fifty-five (45.1%) children required escalation of respiratory support and 18 (14.8%) were transferred to the PICU. Five (4.1%) died during hospitalization. In the multivariable analysis, respiratory comorbidities (aOR: 3.36 [CI95 1.41, 8.01]) were associated with increased odds of escalation of respiratory support. Conclusions HA-RSV infections cause preventable morbidity and increase healthcare resource utilization. Further study of effective mitigation strategies for HA-respiratory viral infections should be prioritized; this priority is further supported by the impact of the COVID-19 pandemic on seasonal viral infections. |
| Document Type: |
article in journal/newspaper |
| Language: |
English |
| DOI: |
10.1093/jpids/piad030 |
| DOI: |
10.1093/jpids/piad030/50212269/piad030.pdf |
| Availability: |
https://doi.org/10.1093/jpids/piad030; https://academic.oup.com/jpids/advance-article-pdf/doi/10.1093/jpids/piad030/50212269/piad030.pdf; https://academic.oup.com/jpids/article-pdf/12/5/265/50494967/piad030.pdf |
| Rights: |
https://creativecommons.org/licenses/by/4.0/ |
| Accession Number: |
edsbas.256E8D87 |
| Database: |
BASE |